In adult rats, the extension peptide on the analogue LR3IGF-I did not protect IGF-I from degradation in the upper gut.
In plain wordsIn rats, the added tail on LR3IGF-I did not protect IGF-I from breakdown in the upper gut.
- Peptide
- IGF-1 LR3
- Outcome
- No significant changeGut survival of IGF-I with the LR3IGF-I extension peptide
- Study
ratn: not reported in source
Ligated gut segments of fasted adult rats- Outcome group
- Pharmacokinetics · Pharmacology
- Studied dose
- Dose not stated
Source sentences
the extension peptide on the analogue, LR3IGF-I did not protect IGF-I
1 context sentence(design, population, supporting numbers)
To investigate the potential of IGF-I peptides as therapeutics in the gut, the survival profiles of a bolus of 125I-labelled IGF-I (8.6 ng) in vivo in various ligated gut segments of fasted adult rats have been examined.